Complete IPO calendar at IPOpremium.com
Ordered by size of IPO.
1. Markit Ltd. ($MRKT)
Based in New York, NY, Markit Ltd. scheduled a $1.1 billion IPO on the Nasdaq with a market capitalization of $4.3 billion at a price range midpoint of $24 for Thursday, June 19, 2014.
MRKT is a leading global diversified provider of financial information services. MRKT’s offerings enhance transparency, reduce risk and improve operational efficiency in the financial markets.
2. Eclipse Resources ($ECR)
Based in State College, PA, Eclipse Resources scheduled a $863 million IPO on the NYSE with a market capitalization of $3.7 billion at a price range midpoint of $28.50 for Friday, June 20, 2014.
ECR is an independent exploration and production company engaged in the acquisition and development of oil and natural gas properties in the Appalachian Basin.
3. Foresight Energy Partners LP ($FELP)
Based in St. Louis, MO, Foresight Energy Partners LP scheduled a $350 million IPO on the NYSE with a market capitalization of $2.6 billion at a price range midpoint of $20 for Wednesday, June 18, 2014.
FELP is a holding company with no independent operations or assets. Distributions to unitholders are dependent on cash flow generated by subsidiaries. FELP believes it is the lowest cost and highest margin bituminous thermal coal producer in the United States.
4. Century Communities (CCS)
Based in Greenwood Village, CO, Century Communities scheduled a $110 million IPO on the NYSE with a market capitalization of $526 million at a price range midpoint of $24.50 for Wednesday, June 18, 2014.
CCS is engaged in all aspects of homebuilding, including land acquisition and development, entitlements, and the acquisition, development, construction, marketing, sale and management of various residential projects in major metropolitan markets in Colorado, and, more recently, in the greater Austin and San Antonio, Texas and Las Vegas, Nevada metropolitan areas.
5. Viper Energy Partners LP ($VNOM)
Based in Midland, TX, Viper Energy Partners LP scheduled a $100 million IPO on the Nasdaq with a market capitalization of $1.5 billion at a price range midpoint of $20 for Wednesday, June 18, 2014.
VNOM is a Delaware limited partnership formed by Diamondback (FANG) to own, acquire and exploit oil and natural gas properties in North America.
VNOM’s initial assets consist of mineral interests in oil and natural gas properties in the Permian Basin in West Texas, substantially all of which are leased to working interest owners who bear the costs of operation and development.
6. Kite Pharma ($KITE)
Based in Santa Monica, CA, Kite Pharma scheduled a $78 million IPO on the Nasdaq with a market capitalization of $474 million at a price range midpoint of $13 for Friday, June 20, 2014.
KITE is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to eradicate cancer cells.
7. Syndax Pharmaceuticals ($SNDX)
Based in Waltham, MA, Syndax Pharmaceuticals scheduled a $60 million IPO on the Nasdaq with a market capitalization of $171 million at a price range midpoint of $14 for Thursday, June 19, 2014.
SNDX is a late-stage biopharmaceutical company focused on the development and commercialization of its lead product candidate, entinostat, an epigenetic therapy for treatment-resistant cancers.
8. ZS Pharma ($ZSPH)
Based in Coppell, TX, ZS Pharma scheduled an $80 million IPO on the Nasdaq with a market capitalization of $300 million at a price range midpoint of $16 for Wednesday, June 18, 2014.
ZSPH is a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases.
9. Zafgen ($ZFGN)
Based in Cambridge, MA, Zafgen scheduled a $75 million IPO on the Nasdaq with a market capitalization of $312 million at a price range midpoint of $15 for Thursday, June 19, 2014.
ZFGN is a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity.
10. Parnell Pharmaceuticals Holdings ($PARN)
Based in Alexandria, Australia, Parnell Pharmaceuticals Holdings scheduled a $65 million IPO on the Nasdaq with a market capitalization of $207 million at a price range midpoint of $18 for Wednesday, June 18, 2014.
PARN is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions.
11. Ardelyx ($ARDX)
Based in Fremont, CA, Ardelyx scheduled a $50 million IPO on the Nasdaq with a market capitalization of $241 million at a price range midpoint of $14 for Thursday, June 19, 2014.
ARDX is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative, non-systemic, small molecule therapeutics that work exclusively in the gastrointestinal, or GI, tract to treat cardio-renal, GI and metabolic diseases.
12. Microlin Bio ($MCLB)
Based in New York, NY, Microlin Bio scheduled a $30 million IPO on the Nasdaq with a market capitalization of $75 million at a price range midpoint of $11 for Wednesday, June 18, 2014.
MCLB is a development stage emerging therapeutic and diagnostic company focusing on microRNA and its role in oncology.
Read Next
